Aus coViki
Version vom 8. Juli 2020, 09:50 Uhr von Ossip Groth (Diskussion | Beiträge)
(Unterschied) ← Nächstältere Version | Aktuelle Version (Unterschied) | Nächstjüngere Version → (Unterschied)
Wechseln zu: Navigation, Suche
  • GET ä. The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is ?Safe Better than Sorry?? Extract
  • GET 2020. Covid-19 The real role of NSAIDs in Italy Extract
  • GET 2020. NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators? Extract
  • GET 2020. Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) Extract
  • GET 2020. EMA advice on the use of NSAIDs for Covid-19 Extract
  • GET 2020. Non-steroidal anti-inflammatory drugs and covid-19 Extract
  • GET 2020. Covid-19: European drugs agency to review safety of ibuprofen Extract
  • GET 2020. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists Extract
  • GET 2020. Covid-19: NICE advises against using NSAIDs for fever in patients with suspected cases Extract
  • GET 2020. Regulatory agencies issue advice on use of NSAIDs for COVID-19 Extract
  • GET 2020. Model based approach for estimating the dosage regimen of indomethacin a potential antiviral treatment of patients infected with SARS CoV-2. Extract
  • GET 2020. Non-steroidal anti-inflammatory drugs in management of COVID-19; A systematic review on current evidence. Extract
  • GET 2020. Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2/COVID-19. Extract
  • GET 2020. Covid-19: ibuprofen can be used for symptoms, says UK agency, but reasons for change in advice are unclear. Extract
  • GET 2020. Rapid Review: Nonsteroidal Anti-inflammatory Agents and Aminosalicylates in COVID-19 Infections. Extract
Meine Werkzeuge